200440-13-7

Basic information

• Product Name: Thiazole, 2-(1,1-diMethoxyethyl)-
• Synonyms: Thiazole, 2-(1,1-diMethoxyethyl)-;2-(1,1-dimethoxyethyl)thiazole
• CAS NO: 200440-13-7
• Molecular Formula: C7H11NO2S
• Molecular Weight: 173.23274
• Mol File: 200440-13-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Thiazole, 2-(1,1-diMethoxyethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Thiazole, 2-(1,1-diMethoxyethyl)-(200440-13-7)
• EPA Substance Registry System: Thiazole, 2-(1,1-diMethoxyethyl)-(200440-13-7)

Safety Data

• Hazardous Substances Data: 200440-13-7(Hazardous Substances Data)

Usage

General Description

Thiazole, 2-(1,1-dimethoxyethyl)- is a chemical compound with the molecular formula C7H11NOS. It belongs to the thiazole class of organic compounds that contain a five-membered ring with sulfur and nitrogen atoms. The 2-(1,1-dimethoxyethyl) group is a substituent that consists of two methoxy (O-CH3) groups attached to the carbon atom. Thiazole, 2-(1,1-diMethoxyethyl)- is used in the synthesis of pharmaceuticals and agrochemicals, and it exhibits various biological activities, including antimicrobial and antioxidant properties. Thiazole, 2-(1,1-dimethoxyethyl)- is also used in the production of flavors and fragrances, as well as in the manufacturing of dyes and colorants.

Upstream product

• 24295-03-2 2-Acetylthiazole 
• 149-73-5 trimethyl orthoformate 

Downstream Products

• 1202769-60-5 2-acetylthiazole-5-carbonitrile 
• 774230-95-4 1-(5-chlorothiazol-2-yl)ethan-1-one 
• 774230-98-7 1-(5-bromo-1,3-thiazol-2-yl)ethanone 
• 1000029-34-4 1-(5-phenylthiazol-2-yl)ethanone 

Relevant articles and documents

Synthesis of thiazole analogues of the immunosuppressive agent (1R,25,3A)-2-acetyl-4(5)-(1,2,3,4-tetrahydroxybutyl)imidazole

The synthesis of four of the diastereoisomers of 2-acetyl-5-(l ,2,3,4-tetrahydroxybutyl)thiazole and two of the diastereoisomers of 2-acetyl-5-( 1,2,3,4,5-pentahydroxypentyl)thiazole and 2-acetyl-4-( 1,2,3,4,5-pentahydroxypentyl)thiazole are reported. These syntheses involve the condensation of 5- or 4-metallated 2-( 1,1 -dimethoxyethyl)thiazoles with 2,3-O-isopropylidene-D-erythrono-l,4-lactone or 5-O-(tert-butyldimethylsilyl)-2,3-O-isopropylideneD-ribonolactone followed by reductive ring-opening of the resulting lactols. The stereochemistries and structures of some key compounds have been determined by single crystal X-ray structural analysis.

NLRP3 INHIBITORS

The present application relates to compounds with NLRP3inhibitory activity and to associated salts, solvates, prodrugs and pharmaceutical compositions. The present application further relates to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3inhibition.

FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

no abstract published